Assura’s (AGR) Hold Rating Reiterated at Shore Capital

Shore Capital restated their hold rating on shares of Assura (LON:AGR) in a report published on Tuesday morning, MarketBeat reports.

Assura Trading Up 0.4 %

AGR stock opened at GBX 42.04 ($0.54) on Tuesday. The company has a current ratio of 0.89, a quick ratio of 2.84 and a debt-to-equity ratio of 85.04. The business’s 50 day moving average is GBX 40.97 and its 200-day moving average is GBX 41.59. Assura has a 1-year low of GBX 37.54 ($0.48) and a 1-year high of GBX 49.18 ($0.63). The firm has a market cap of £1.36 billion, a P/E ratio of -4,204.00, a P/E/G ratio of 3.60 and a beta of 0.34.

Assura Increases Dividend

The company also recently disclosed a dividend, which was paid on Wednesday, July 10th. Shareholders of record on Thursday, June 6th were paid a dividend of GBX 0.84 ($0.01) per share. This represents a yield of 1.97%. This is a boost from Assura’s previous dividend of $0.82. The ex-dividend date of this dividend was Thursday, June 6th. Assura’s dividend payout ratio is currently -30,000.00%.

Insider Buying and Selling at Assura

In related news, insider Jayne Cottam acquired 54,700 shares of the stock in a transaction on Wednesday, May 29th. The stock was purchased at an average price of GBX 40 ($0.51) per share, for a total transaction of £21,880 ($27,936.67). In other Assura news, insider Jayne Cottam bought 54,700 shares of the business’s stock in a transaction on Wednesday, May 29th. The shares were bought at an average cost of GBX 40 ($0.51) per share, for a total transaction of £21,880 ($27,936.67). Also, insider Jonathan Murphy bought 198,975 shares of the business’s stock in a transaction on Tuesday, May 21st. The stock was bought at an average cost of GBX 43 ($0.55) per share, for a total transaction of £85,559.25 ($109,243.17). In the last quarter, insiders acquired 304,518 shares of company stock worth $12,727,873. 0.24% of the stock is currently owned by insiders.

Assura Company Profile

Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK – caring for more than 600 primary healthcare buildings, from which over six million patients are served. A constituent of the FTSE 250 and the EPRA indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion.